Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > generic

: 1B-LSD

or Psilocybin

& fda max: Not FDA-approved; clinical-trial protocols use up to 30 mg in adult investigational dosing

Use the filters below to narrow your results.

COMP360 (Compass Pathways, investigational synthesized clinical formulation) (1)

[[:Category:Classical Psychedelics (Serotonergic)|Serotonergic psychedelic]] (1) · [[:Category:Psychedelics|Psychedelic]] (1) · [[:Category:Tryptamines|Tryptamine]] (1)

Prodrug to [[Psilocin|psilocin]] (4-hydroxy-N,N-dimethyltryptamine), a partial agonist at the [[Receptor:5-HT2A|5-HT2A]] serotonin receptor; the action that defines the classical-psychedelic mechanism (1)

(investigational) '"`UNIQ--vote-000000EF-QINU`"', '"`UNIQ--vote-000000F0-QINU`"', '"`UNIQ--vote-000000F1-QINU`"', '"`UNIQ--vote-000000F2-QINU`"', '"`UNIQ--vote-000000F3-QINU`"' (1)

Modern clinical-trial standard: 25 mg synthesized psilocybin, single oral dose with psychological support (1)

Synthesized psilocybin capsules (COMP360 and other investigational formulations); dried whole [[Psilocybe|Psilocybe]] mushrooms (variable potency, no legal supply chain in most jurisdictions); psilocybin truffles (Psilocybe sclerotia, legal in the Netherlands) (1)

Oral (1)

20-45 min subjective onset; psilocin formation from psilocybin requires intestinal and hepatic alkaline phosphatase (1)

4-6 hours (1)

Psilocin: ~2-3 h; psilocybin itself is a prodrug, dephosphorylated within minutes of absorption (1)

Oral bioavailability of psilocin from administered psilocybin approximately 50% (1)

Not studied in human pregnancy; no approved clinical use in any population (1)

None (1)

Showing below up to 1 result in range #1 to #1.

P

Psilocybin

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"